ROY.PHILIPS

Research ROY.PHILIPS (PHI1) on Bullrun: market cap EUR 23.08B, P/E 20.7, dividend yield 3.7%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 23.08B; P/E is 20.7; dividend yield is 3.7%.

Peer valuation comparison

Latest P/E is 20.71x versus a Healthcare sector median of 24.46x (15.3% below).

Latest dividend yield is 3.68% versus a Healthcare sector median of 2.11% (74.4% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025EUR 17.83BEUR 897.00MEUR 502.00M45.2%0.93EUR 2.79BEUR 6.93BEUR 10.96B
FY2024EUR 18.02B-EUR 698.00Mn/a43.1%-0.75EUR 2.40BEUR 7.11BEUR 12.01B
FY2023EUR 18.17B-EUR 463.00Mn/a41.0%-0.49EUR 1.87BEUR 7.04BEUR 12.06B
FY2022EUR 17.83B-EUR 1.61Bn/a40.4%-1.69EUR 1.17BEUR 7.27BEUR 13.28B

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-23EUR 23.08B20.73.6%0.85

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0.85 EUR, yield 3.7%.

YearDividends/share
FY20250.85 EUR
FY20220.79 EUR

About ROY.PHILIPS

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is ROY.PHILIPS's market cap?

ROY.PHILIPS's market capitalization is EUR 23.08B.

What is ROY.PHILIPS's P/E ratio?

ROY.PHILIPS's price-to-earnings (P/E) ratio is 20.7.

Does ROY.PHILIPS pay a dividend?

ROY.PHILIPS has a dividend yield of 3.7%.

What does ROY.PHILIPS do?

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V.